Terry-Ann Burrell, CFO at Beam Therapeutics Inc. (BEAM), sold 3,574 shares at $59.11 ($211K) on 2022-03-31, disclosed to the SEC on 2022-04-04.
Open-market sale of $211k BEAM by CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $59.11 | 1,787 | $106K | 50.0% |
| 2 | $59.11 | 1,787 | $106K | 50.0% |
| Total | $59.11 avg | 3,574 | $211K | 100% |
| Filing → |
| BEAM | SELL | 2023-04-05 | $276K | — | Filing → |
| BEAM | SELL | 2023-01-30 | $3.3M | — | Filing → |
| BEAM | SELL | 2023-01-25 | $1.8M | — | Filing → |